We have located links that may give you full text access.
Reduction In Exposure To Selected Harmful And Potentially Harmful Constituents Approaching Those Observed Upon Smoking Abstinence In Smokers Switching To The Menthol Tobacco Heating System 2.2 For Three Months (Part 1).
Nicotine & Tobacco Research 2019 Februrary 6
Introduction: The Tobacco Heating System (THS) is a "heat-not-burn" tobacco product designed to generate significantly lower levels of harmful and potentially harmful constituents (HPHC) and present lower risk of harm than cigarettes. This study assessed the exposure reduction to selected HPHC in smokers switching to menthol THS (mTHS) 2.2 compared with smokers continuing smoking menthol cigarettes (mCC) and smoking abstinence (SA) for five days in a confined setting, followed by an 86-day ambulatory period.
Methods: One hundred sixty healthy adult U.S. smokers participated in this randomized, three-arm parallel group, controlled clinical study. Biomarkers of exposure to 16 HPHCs were measured in blood and 24-hour urine. Safety was monitored throughout the study. Information was also gathered on product evaluation, product use, subjective effects, and clinical risk markers (co-publication Part 2).
Results: Nicotine uptake was comparable in both exposure groups (mTHS:mCC ratio of 96% on Day 90). On Day 5, biomarker of exposure levels to other HPHCs were reduced by 51% to 96% in the mTHS group compared with the mCC group, and these reductions were sustained for most biomarkers over the ambulatory period. After 90 days of use, the level of satisfaction with mTHS and suppression of urge to smoke were comparable to mCC.
Conclusion: Switching from mCCs to mTHS significantly reduced the exposure to HPHCs to levels approaching those observed in subjects who abstained from smoking for the duration of the study.
Methods: One hundred sixty healthy adult U.S. smokers participated in this randomized, three-arm parallel group, controlled clinical study. Biomarkers of exposure to 16 HPHCs were measured in blood and 24-hour urine. Safety was monitored throughout the study. Information was also gathered on product evaluation, product use, subjective effects, and clinical risk markers (co-publication Part 2).
Results: Nicotine uptake was comparable in both exposure groups (mTHS:mCC ratio of 96% on Day 90). On Day 5, biomarker of exposure levels to other HPHCs were reduced by 51% to 96% in the mTHS group compared with the mCC group, and these reductions were sustained for most biomarkers over the ambulatory period. After 90 days of use, the level of satisfaction with mTHS and suppression of urge to smoke were comparable to mCC.
Conclusion: Switching from mCCs to mTHS significantly reduced the exposure to HPHCs to levels approaching those observed in subjects who abstained from smoking for the duration of the study.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app